Literature DB >> 1580807

Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis.

J Pittman1, H Andrews, T Tatemichi, B Link, E Struening, Y Stern, R Mayeux.   

Abstract

Each of 430 subjects received a diagnosis using two independent methods: a test-based quantitative paradigm and a semistructured neurological examination by a physician. The paradigm diagnosis was based on a battery of tests that assessed short- and long-term verbal memory and short-term nonverbal memory, orientation, construction, abstract reasoning, and language. The subjects came from a community in Manhattan County, in New York City, and were characterized by diversity with respect to both ethnicity (29.1% black, 33.4% Hispanic) and educational level (23.5% with 6 or fewer years of education, 25.6% college educated). Based on the paradigm, 10.5% of subjects received diagnoses of dementia, 29.1% of cognitive impairment, and 60.5% of normal. Based on the physician's diagnosis, 9.8% were demented, 21.6% cognitively impaired, and 68.6% normal. There was agreement between the two diagnostic methods for 71.8% of subjects. Diagnostic disagreement (n = 121) was in most cases between normal and cognitively impaired (71.0%) or between cognitively impaired and demented (21.5%). There were only nine cases (7.5%) in which a subject was judged demented by one method and normal by the other. The reliability of each method with respect to the other was moderate (intraclass correlation coefficient, .62), while the reliability of a composite diagnosis based on both methods was much higher (.77). The paradigm was more likely than the physician to give the diagnosis of dementia to patients with low educational levels. The physician's diagnosis was strongly influenced by measures of functioning and by the mental status test administered in the semistructured neurological examination. Race and diagnosis were not related when the effect of education was controlled.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1580807     DOI: 10.1001/archneur.1992.00530290043010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  23 in total

1.  Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.

Authors:  Laurel Vana; Nicholas M Kanaan; Isabella C Ugwu; Joanne Wuu; Elliott J Mufson; Lester I Binder
Journal:  Am J Pathol       Date:  2011-09-23       Impact factor: 4.307

2.  Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.

Authors:  Cassia R Overk; Christian C Felder; Yuan Tu; Doug A Schober; Kelly R Bales; Joanne Wuu; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2010-03-27       Impact factor: 3.052

3.  Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease.

Authors:  J H Lee; R Cheng; L S Honig; J-P G Vonsattel; L Clark; R Mayeux
Journal:  Neurology       Date:  2007-10-31       Impact factor: 9.910

4.  Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.

Authors:  Joseph H Lee; Sandra Barral; Rong Cheng; Inara Chacon; Vincent Santana; Jennifer Williamson; Rafael Lantigua; Martin Medrano; Ivonne Z Jimenez-Velazquez; Yaakov Stern; Benjamin Tycko; Ekaterina Rogaeva; Yosuke Wakutani; Toshitaka Kawarai; Peter St George-Hyslop; Richard Mayeux
Journal:  Neurogenetics       Date:  2007-10-17       Impact factor: 2.660

5.  Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics.

Authors:  R Mayeux; J H Lee; S N Romas; D Mayo; V Santana; J Williamson; A Ciappa; H Z Rondon; P Estevez; R Lantigua; M Medrano; M Torres; Y Stern; B Tycko; J A Knowles
Journal:  Am J Hum Genet       Date:  2001-11-19       Impact factor: 11.025

6.  Effect of smoking and time on cognitive function in the elderly without dementia.

Authors:  Christiane Reitz; Jose Luchsinger; Ming-Xin Tang; Richard Mayeux
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

7.  Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.

Authors:  J H Lee; R Mayeux; D Mayo; J Mo; V Santana; J Williamson; A Flaquer; A Ciappa; H Rondon; P Estevez; R Lantigua; T Kawarai; A Toulina; M Medrano; M Torres; Y Stern; B Tycko; E Rogaeva; P St George-Hyslop; J A Knowles
Journal:  Mol Psychiatry       Date:  2004-11       Impact factor: 15.992

8.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

9.  Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.

Authors:  Chelsea T Tiernan; Elliott J Mufson; Nicholas M Kanaan; Scott E Counts
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

10.  A Link between Subjective Perceptions of Memory and Physical Function: Implications for Subjective Cognitive Decline.

Authors:  Stephanie Cosentino; Davangere Devanand; Barry Gurland
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.